Beijing University of Chinese Medicine is the lead sponsor of 6 current clinical trials in our China register. 2 are recruiting patients now. The most common phase is Not applicable. The most-studied condition is HIV-1 Infection.
| Study | Phase | Status | Start | Registers |
|---|---|---|---|---|
|
Risk Assessment and Syndrome Evolution Models for Chronic Atrophic Gastritis Malignant Transformation
NCT03261934 · ClinicalTrials.gov ↗ · Risk Assessment of Chronic Atrophic Gastritis Malignant Transformation
|
Observational | Recruiting | 2018-01 | China |
|
A Trial of Shengmai Liquid for Long COVID Fatigue.
NCT06980636 · ClinicalTrials.gov ↗ · Long COVID Fatigue
|
Phase 4 | Recruiting | 2025-12 | China |
|
Yanlishuang Buccal Dropping Pills for Acute Pharyngitis
NCT07761013 · ClinicalTrials.gov ↗ · Acute Pharyngitis
|
Not applicable | Not yet open | 2026-08 | China |
|
Noninvasive Early Diagnosis of Colorectal Cancer Using Odor-Targeted Capture, Point-of-Care Testing, and Intelligent Analysis
NCT07620743 · ClinicalTrials.gov ↗ · CRC, Precancerous Condition, Healthy
|
Observational | Not yet open | 2026-06 | China |
|
Fuyang Jiedu Granules Plus Antiretroviral Therapy for HIV Immune Non-Responders With Spleen-Kidney Yang Deficiency
NCT07698548 · ClinicalTrials.gov ↗ · HIV-1 Infection, Acquired Immunodeficiency Syndrome, Immune Reconstitution Failure
|
Not applicable | Not yet open | 2026-08 | China |
|
Qiling Yiqi Tablets Plus Antiretroviral Therapy for HIV Immune Non-responders With Lung-Spleen Qi Deficiency
NCT07698574 · ClinicalTrials.gov ↗ · HIV-1 Infection, Acquired Immunodeficiency Syndrome, Immune Reconstitution Failure
|
Not applicable | Not yet open | 2026-08 | China |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.
| Register | Trials | Recruiting |
|---|---|---|
| Clinical trials in China | 6 | 2 |
A trial with sites in more than one country appears in each of those registers.
| Sponsor | Trials |
|---|---|
| Henan Genuine Biotech | 1 |
Sponsors with the most current trials registered for this condition.
Beijing University of Chinese Medicine is the lead sponsor of 6 current trials on ClinicalTrials.gov in our China register, as of the registry sync on 26 September 2026. Completed and withdrawn studies are not counted.
Yes. 2 of its 6 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.
Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.
Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.
This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 26 Sep 2026.